Abstract
Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study † A multidisciplinary tumour board (MTB) brings together all teams involved in a patient's care, including physicians (oncologists, radiologists, anaesthetists, surgeons, pulmonologists and pathologists), nurses, social workers, dieticians, physiotherapists and occupational therapists. The MTB members share their expertise, professional perspective and knowledge, and conferences are designed to enhance patient management and outcomes. Despite the absence of randomized trials, indirect evidence has shown a measureable improvement in outcomes since the introduction of multidisciplinary cancer care. However, the ability to measure the true effect of multidisciplinary care on cancer survival is limited by the inability to disentangle the effects of socioeconomic status, health service deprivation and heterogeneity of tumour stage from those secondary to implementation of a multidisciplinary approach and inherent improvements in cancer treatments over time.
Although some data are available suggesting that managing lung cancer patients within an MTB results in timely access to treatment and adherence to guidelines, to date, specific evidence is not available regarding the impact of this model of lung cancer care on survival or patient satisfaction [1] .
The aim of this study is to evaluate the impact of lung cancer MTB on different outcomes including 1-year survival by comparing patients treated before and after the establishment of a prospective, multidisciplinary care conference.
METHODS

Study design and population
This study was conducted at the Ferrara University Hospital, which is a tertiary centre for thoracic surgery. A multidisciplinary thoracic tumour board responsible for the management of patients with known or suspected lung, pleural or mediastinal malignancies was established in 2012.
The MTB meeting is held weekly and attendees include surgeons, pulmonary oncologists, radiation oncologists, radiologists, nuclear medicine specialists, pulmonologists, pathologists, lung cancer care coordinators and trainees. A management strategy is formulated and documented for each patient at the MTB meeting. An MTB database is created to assist with patient management. The data collected include patient demographics, smoking and occupational exposures, clinical parameters, patient performance status and comorbidities, tumour characteristics, treatment methods and survival. This retrospective cohort analysis is performed with the permission of the institutional ethics board.
All consecutive patients who underwent surgery with curative intent for non-small-cell lung cancer (NSCLC) at our department between January 2008 and December 2015 were identified using the MTB and institution's database. A retrospective analysis of these patient records was performed.
Demographic data, completeness of staging, multidisciplinary evaluation prior to the initiation of therapy, preoperative diagnosis, pathological stages, surgical procedure, completeness of resection, hospital stay, postoperative complications and 1-year survival were all assessed. Overall survival was calculated from the day of surgery. Performance status was classified according to the Eastern Co-operative Oncology Group (ECOG) score [2] and comorbidities and postoperative complications were defined according to the Charlson Comorbidity Index Score [3] and the Ottawa thoracic morbidity and mortality classification system score [4] , respectively.
During the period under evaluation, the seventh edition of the tumour, node and metastasis (TNM) staging system replaced the sixth edition. Therefore, for this analysis, all patients were restaged using the seventh edition of the TNM staging system [5] based on information from bronchoscopy/endobronchial ultrasound/oesophageal ultrasound, computed tomography scan, fluorodeoxyglucose-positron emission tomography scan and a magnetic resonance imaging or computed tomography of the brain and the final pathology report.
Two study groups were identified based on whether patients had their care prospectively coordinated through the institution's multidisciplinary thoracic malignancy care conference or were treated prior to the conference's implementation.
Exclusion criteria included patient refusal of treatment following diagnosis, patients with superior sulcus tumours, patients undergoing surgery for NSCLC metastasis according to the Martini and Metamed criteria [6] and patients undergoing surgery with diagnostic or palliative intent.
Complete preoperative evaluation
The minimum preoperative evaluation was defined as a minimum of computed tomography scan, including the chest, upper abdomen and adrenal glands, positron emission tomography, bronchoscopy, complete blood count, electrolyte profile, pulmonary function tests and further evaluation of any specific symptoms.
Statistical analysis
Propensity score matching was performed to create 2 groups with no difference with respect to confounding factors. Propensity score was estimated using the logistic regression model with discussion of the MTB as the outcome. The following explanatory variables were included in the analysis: age, sex, the ECOG score >0, the Charlson Comorbidity Index, neoadjuvant therapy and pneumonectomy (Table 1) . Patients were matched using the 'nearest neighbour' procedure with a maximum difference in propensity score of 10% of its standard deviation.
Continuous data were expressed as means ± standard deviation or as median and interquartile range (IQR), whereas categorical variables were summarized as absolute frequencies and percentages. After propensity score matching was performed, differences between the 2 groups (MTB no/yes and alive/deceased after 1 year) were assessed using the v 2 test or the Fisher's exact test for categorical variables and the Student's t-test or the nonparametric Mann-Whitney U-test for continuous data, as appropriate. To evaluate the significance of the MTB discussion as a factor for the outcome of 1-year mortality after surgical treatment, a simple Cox regression model was carried out. To measure the net effect of the MTB, the model was then adjusted adding on the variables that were significantly associated with death. Finally, unnecessary variables were removed using a stepwise backward selection technique (P-value for removal = 0.1), and a more parsimonious multiple model was obtained; hazard ratios and their 95% confidence interval were reported. Results were considered statistically significant at P < 0.05. All analyses were performed using R version 3. 
RESULTS
Patient and treatment characteristics
In total, 488 consecutive patients with NSCLC were treated and included in this study. Eleven patients were excluded because of lack of patients' charts. In the remaining 477 patients, 246 were treated before the MTB implementation and 231 patients underwent surgery after the MTB discussion, 45 of whom were treated after 2012 without the MTB evaluation and were, therefore, excluded from our analysis.
During the study period, an increased proportion of cases undergoing surgery for lung cancer was presented at the MTB meeting ( Fig. 1 ): in 2015, 92% of cases were presented during the MTB meeting, whereas in 2012, only 46% of cases were discussed.
Demographic data for the 2 groups are summarized in Table 1 . In the MTB discussion group, a lower proportion of men and mean age can be noted. Furthermore, significantly more patients in the MTB group underwent lung resection by video-assisted thoracoscopic surgery when compared with the non-MTB group (48% vs 9%). All the other variables were comparable between the 2 groups. Specifically, the distribution of tumour histology, smoking history and chronic obstructive pulmonary disease did not differ significantly between the 2 groups. The mean Charlson Comorbidity Index was 4.7, and a similar proportion of patients undergoing neoadjuvant and adjuvant treatments was observed in both groups.
Two homogeneous groups of 170 patients each (the no MTB discussion and MTB discussion groups) were identified based on the propensity score including 6 different variables. The demographic, clinical and histological characteristics of both groups are summarized in Table 2 .
Analysis of the propensity-matched groups for postoperative outcomes demonstrated that patients who were discussed at MTBs were associated with significantly lower advanced TNM stages: 26 (15%) patients who were discussed at MTBs before surgery were affected by Stages III and IV NSCLC, as compared to 41 (24%) patients who were not (P = 0.041). Furthermore, the MTB discussion group was associated with a higher rate of complete preoperative evaluation (P < 0.001). There was no difference in the incidence of exploratory thoracotomy, completeness of resection, postoperative complications and postoperative mortality. One-year mortality was significantly lower in the MTB group (18% vs 8% P = 0.006).
The variables associated with 1-year mortality are listed in Table 3 . Forty-three (13%) patients died within 1 year after the surgery.
Performance status and patient comorbidities were significantly associated with negative 1-year survival rates in both groups. The factors such as patients with TNM Stages III and IV, non-therapeutic thoracotomy, postoperative complications, neoadjuvant therapies and completeness of resection were related to poor 1-year survival.
Furthermore, patients who were treated within the thoracic malignancy care board and those who underwent a complete preoperative evaluation were found to have a significantly better 1-year survival when compared with patients diagnosed before the establishment of the conference. Figure 2 shows a Kaplan-Meier curve comparing the 2 groups. The Cox regression model was fitted to assess factors that were associated with survival: patients undergoing the MTB discussion were found to have a better 1-year survival (odds ratio 0.48; 95% confidence interval 0.25-0.92).
Follow-up and survival
DISCUSSION
Patients affected by NSCLC require multimodal treatment with a combination of surgery, systemic chemotherapy and radiotherapy. This approach can have a palliative or curative intent and can involve multiple physicians and other healthcare professionals over the treatment period.
The MTB provides an environment in which physicians and other healthcare professionals can discuss relevant diagnostic, pathological and therapeutic aspects of patient care [7] . The format of the MTB varies from roundtable discussions involving team members without the presence of the patient to a more hands-on approach in which the patient is present and is examined by the team members. Moreover, MTBs are now considered to be an integral part of the management of oncological patients in many tertiary care centres.
In the UK, MTBs exist since 1995, and currently, more than 80% of cancer patients in the UK are assessed by an MTB, as compared to only 20% of patients a decade earlier [8] [9] [10] .
Patients with malignancies other than lung cancer have also been shown to benefit from coordinated multidisciplinary care. Baldwin et al. [11] and Fairchild et al. [12] observed measurable benefits in the care of patients with breast cancer, including higher rates of breast conservation, multimodality therapy and pain management.
Based on the previous discussion, it would seem intuitive that a prospective multidisciplinary care conference would benefit patients with lung cancer. However, challenges of implementing multidisciplinary care remain, and many centres must take responsibility to improve the process [13] . Furthermore, robust evidence to suggest improvement on outcomes in patients with NSCLC is lacking, which contributes to scepticism regarding MTB patient management.
Our investigation sought to evaluate the impact of the MTB on survival by comparing 2 groups of patients with lung cancer treated by the same physicians at a tertiary care hospital before and after the establishment of an MTB. Few studies have evaluated MTBs for lung cancer, and most of them are focused on inoperable tumours. Ung et al. [14] assessed the impact of MTB meetings on patient management plans, and found that MTB recommendations on patient care were taken into consideration in 72% of cases. A prospective study by Leo et al. [15] involving 344 patients showed that patient discussion at MTBs led to discordance in 15 (4.4%) cases with a nonstatistically significant trend toward an increase in survival in patients treated using a multidisciplinary care conference. Forrest et al. [16] compared survival in 2 groups of patients with inoperable lung cancer before and after implementation of a multidisciplinary team. The authors observed a significant increase in the number of patients receiving chemotherapy and an increased median survival after implementation of the team (3.2 months vs 6.6 months, P < 0.001). Similarly, Price et al. [17] observed a significant increase in radical radiotherapy administration and an improved 1-year survival rate (18.3% vs 23.5%) in patients with NSCLC after the introduction of MTBs. Another retrospective institutional review [18] showed that patients with advanced NSCLC evaluated at MTBs were more likely to receive chemoradiation and chemotherapy with a median survival benefit as compared to patients who were not (237 days vs 208 days). In contrast, Boxer et al. [19] analysed patient and tumour characteristics and treatment receipt in 988 cases treated for primary lung cancer. They observed that MTB discussion was related to better receipt of radiotherapy and chemotherapy in patients with stage IV NSCLC but did not influence survival. A prospective study involving 221 patients concluded that MTB does not improve the overall quality of clinical decision-making [20] . This study analysed the adherence to the treatment option provided by the lung cancer MTB and reported that in 50 cases, the treating physician did not follow the MTB's recommendation, leading to the conclusion that the impact of team discussion was not significant. This study presents 2 principal findings. First, the proportion of patients undergoing complete preoperative investigations increased significantly following MTB introduction with a lower proportion of advanced stage cancer patients undergoing surgery. Second, a significant increase in survival for patients managed through the MTB was observed: a survival benefit of 92% after surgery with MTB discussion was found, as compared to 82% after surgery without MTB evaluation.
Coory et al. [21] conducted a systematic review assessing the effectiveness of the MTB in lung cancer. Of the 16 studies that met the review inclusion criteria, only 2 reported that MTBs led to an improvement in survival. The authors concluded that current evidence on the MTB is stronger for improving patient management than for affecting survival. Although the MTB affects clinical decision-making, the results do not necessarily translate into improvements in patient care and overall survival.
Multidisciplinary discussion provides an evidence-based approach to treat patients and care is standardized according to international guidelines and a positive environment allows clinicians to share their experience and knowledge [22] .
The survival benefit was probably due to both the reduction in the number of advanced stage cancer patients proceeding to surgery, a more accurate selection of patients and the increased cumulative experience of the different specialists. These findings have led us to recommend the management of all cancer patients in an MTB at our institution, irrespective of staging.
Limitations
Although this study is unique in its design and subject, it does have some limitations. This investigation represents a single institution's experience, the cohort of patients was assessed retrospectively, and we acknowledge that there is inherent bias associated with this approach. Prospective studies and analysis are required to test the role of this multidisciplinary approach in lung cancer patient treatment. Furthermore, the number of patients is relatively small, but the results nonetheless demonstrate what can be achieved by specialist care in a large district general hospital.
CONCLUSION
In conclusion, this study supports the view that multiprofessional lung cancer management improves the quality of care received by patients with NSCLC and the 1-year survival rate.
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